谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Updated Overall Survival Analysis from IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1–selected NSCLC

Jacek Jassem,Filippo de Marinis,Giuseppe Giaccone,Alain Vergnenegre,Carlos H. Barrios,Masahiro Morise,Enriqueta Felip,Cristina Oprean,Young-Chul Kim,Zoran Andric,Simonetta Mocci,Ida Enquist,Kimberly Komatsubara,Mark McCleland,Hiroshi Kuriki,Monette Villalobos,See Phan,David R. Spigel,Roy S. Herbst

Journal of Thoracic Oncology（2021）

引用 66|浏览20
暂无评分
关键词
Atezolizumab,Chemotherapy,PD-L1,NSCLC,IMpower110
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要